Bank of Nova Scotia
ABBV icon

Bank of Nova Scotia’s AbbVie ABBV Stock Holding History

Bank of Nova Scotia’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$71.9M Sell
330,712
-386,275
-54% -$85.7M 0.13% 137
2025
Q4 		$164M Buy
716,987
+193,709
+37% +$44.1M 0.24% 73
2025
Q3 		$121M Buy
523,278
+321,177
+159% +$65.4M 0.21% 85
2025
Q2 		$37.5M Sell
202,101
-42,931
-18% -$7.98M 0.08% 186
2025
Q1 		$51.3M Sell
245,032
-643,670
-72% -$125M 0.12% 148
2024
Q4 		$158M Buy
888,702
+51,554
+6% +$9.48M 0.28% 60
2024
Q3 		$165M Sell
837,148
-125,091
-13% -$23.3M 0.33% 54
2024
Q2 		$165M Buy
962,239
+86,501
+10% +$14.3M 0.32% 51
2024
Q1 		$159M Sell
875,738
-242,565
-22% -$41.8M 0.32% 54
2023
Q4 		$173M Buy
1,118,303
+118,379
+12% +$17.3M 0.32% 62
2023
Q3 		$149M Sell
999,924
-35,205
-3% -$5.17M 0.39% 51
2023
Q2 		$139M Sell
1,035,129
-143,131
-12% -$21M 0.37% 52
2023
Q1 		$188M Buy
1,178,260
+169,705
+17% +$25.9M 0.56% 32
2022
Q4 		$163M Buy
1,008,555
+174,935
+21% +$26.8M 0.42% 46
2022
Q3 		$112M Sell
833,620
-32,652
-4% -$4.69M 0.36% 48
2022
Q2 		$133M Sell
866,272
-199,119
-19% -$30.4M 0.32% 65
2022
Q1 		$173M Sell
1,065,391
-67,729
-6% -$9.84M 0.29% 73
2021
Q4 		$153M Buy
1,133,120
+253,978
+29% +$30M 0.21% 103
2021
Q3 		$94.8M Buy
879,142
+100,994
+13% +$11.5M 0.17% 125
2021
Q2 		$87.7M Sell
778,148
-184,403
-19% -$20.8M 0.16% 123
2021
Q1 		$104M Sell
962,551
-70,477
-7% -$7.54M 0.2% 109
2020
Q4 		$111M Buy
1,033,028
+282,649
+38% +$27.2M 0.24% 92
2020
Q3 		$65.7M Buy
750,379
+673,629
+878% +$63.4M 0.18% 118
2020
Q2 		$7.54M Sell
76,750
-476,832
-86% -$42M 0.03% 348
2020
Q1 		$42.2M Buy
553,582
+194,186
+54% +$16.5M 0.14% 136
2019
Q4 		$31.8M Sell
359,396
-45,884
-11% -$3.81M 0.08% 213
2019
Q3 		$30.7M Sell
405,280
-754,650
-65% -$51.7M 0.09% 197
2019
Q2 		$82.5M Buy
1,159,930
+111,906
+11% +$8.8M 0.35% 64
2019
Q1 		$84.5M Buy
1,048,024
+556,577
+113% +$45.5M 0.33% 68
2018
Q4 		$45.3M Sell
491,447
-152,882
-24% -$13.4M 0.21% 104
2018
Q3 		$60.9M Buy
644,329
+478,302
+288% +$45.4M 0.27% 75
2018
Q2 		$15.4M Sell
166,027
-104,871
-39% -$10.2M 0.08% 193
2018
Q1 		$25.6M Sell
270,898
-253,613
-48% -$27.9M 0.13% 147
2017
Q4 		$50.7M Buy
524,511
+127,607
+32% +$12M 0.23% 99
2017
Q3 		$35.3M Sell
396,904
-82,344
-17% -$6.27M 0.21% 115
2017
Q2 		$34.8M Sell
479,248
-127,073
-21% -$8.54M 0.18% 113
2017
Q1 		$39.5M Buy
606,321
+453,955
+298% +$28.5M 0.17% 118
2016
Q4 		$9.54M Buy
152,366
+24,209
+19% +$1.48M 0.05% 201
2016
Q3 		$8.08M Buy
128,157
+11,670
+10% +$755K 0.05% 179
2016
Q2 		$7.21M Buy
116,487
+85,890
+281% +$5.23M 0.04% 183
2016
Q1 		$1.75M Sell
30,597
-90
-0.3% -$5.02K 0.01% 314
2015
Q4 		$1.82M Sell
30,687
-122
-0.4% -$7.03K 0.01% 346
2015
Q3 		$1.68M Sell
30,809
-76
-0.2% -$4.95K 0.01% 279
2015
Q2 		$2.08M Buy
30,885
+3,660
+13% +$239K 0.01% 227
2015
Q1 		$1.59M Buy
27,225
+334
+1% +$20.2K 0.01% 241
2014
Q4 		$1.76M Buy
26,891
+560
+2% +$35.3K 0.01% 235
2014
Q3 		$1.52M Buy
26,331
+1,233
+5% +$68.5K 0.01% 249
2014
Q2 		$1.42M Sell
25,098
-554,194
-96% -$29.1M 0.01% 254
2014
Q1 		$29.8M Buy
579,292
+357,093
+161% +$18M 0.12% 101
2013
Q4 		$11.7M Buy
222,199
+200,576
+928% +$9.86M 0.05% 153
2013
Q3 		$966K Sell
21,623
-2,585
-11% -$115K ﹤0.01% 270
2013
Q2 		$1M Buy
+24,208
New +$1.06M 0.01% 239

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of Nova Scotia's ABBV Position: Q1 2026 in Review

Bank of Nova Scotia reduced its AbbVie (ABBV) stake by 54% in Q1 2026, selling an estimated $85.7M and leaving 330,712 shares worth $71.9M. The position accounts for 0.13% of the portfolio, ranked #137.

Bank of Nova Scotia first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. The position peaked at $188M in Q1 2023. 4,080 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Bank of Nova Scotia held 330,712 shares of AbbVie worth $71.9M as of Q1 2026.
  • Bank of Nova Scotia sold 386,275 AbbVie shares in Q1 2026, an estimated $85.7M.
  • AbbVie made up 0.13% of Bank of Nova Scotia's portfolio in Q1 2026, its #137 holding.
  • Bank of Nova Scotia first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
  • Bank of Nova Scotia's AbbVie position peaked at $188M in Q1 2023.
  • 4,080 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Bank of Nova Scotia's 13F filing for Q1 2026, filed 14 May 2026.